NEW YORK ( TheStreet) -- BioMarin Pharmaceuticals (Nasdaq: BMRN) hit a new 52-week high Thursday as it is currently trading at $35.69, above its previous 52-week high of $35.60 with 335,111 shares traded as of 12:25 p.m. ET. Average volume has been 806,300 shares over the past 30 days. BioMarin has a market cap of $3.99 billion and is part of the health care sector and drugs industry. Shares are up 2.7% year to date as of the close of trading on Wednesday. BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter